Delphi
Funds bold R&D for modular chiplet-based wearable and ingestible biosensors to enable continuous, real-time monitoring of deep biological signals for proactive health management.
Funder: Advanced Research Projects Agency for Health
Due Dates: April 8, 2026 (Solution Summary) | May 13, 2026 (Full Proposal)
Funding Amounts: No fixed ceiling; awards sized to project needs, multi-year, milestone-based, typically substantial ARPA-scale funding.
Summary: Funds bold, modular biosensor R&D to enable continuous, real-time monitoring of deep biological signals via wearable and ingestible chiplet-based devices.
Key Information: Solution Summary is required to submit a full proposal; teaming across disciplines is strongly encouraged.
Description
This opportunity seeks to transform health monitoring by supporting the development of next-generation, modular biosensors using a “chiplet” approach. The program aims to enable continuous, real-time measurement of deep biological signals—such as hormones, cytokines, and therapeutic drug levels—through discreet, low-cost, wearable or ingestible devices. By leveraging modular, mix-and-match chiplets for sensing, data transmission, and biocompatible packaging, the program intends to create a scalable ecosystem for biosensor innovation. The initiative targets breakthroughs in microelectronics, materials science, secure communications, and bioanalytical chemistry, with the goal of empowering both clinicians and individuals to detect early disease, optimize treatment, and promote proactive health management.
